[HTML] nih.gov

[HTML][HTML] HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer: HMGB1-mediated autophagy promotes gefitinib resistance

T Lei, J Huang, F Xie, J Gu, Z Cheng… - Acta biochimica et …, 2022 - ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) ranks the first in incidence and mortality among
malignant tumors in China. Molecular targeted therapies such as gefitinib, an oral inhibitor of …
被引用次数：9 相关文章

HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer

T Lei, J Huang, F Xie, J Gu, Z Cheng… - Acta biochimica et … - pubmed.ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) ranks the first in incidence and mortality among
malignant tumors in China. Molecular targeted therapies such as gefitinib, an oral inhibitor of …

HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer

L Tianyao, H Jiali, X Fei, G Jingyao… - Acta Biochimica et …, 2022 - agris.fao.org
Non-small cell lung cancer (NSCLC) ranks the first in incidence and mortality among
malignant tumors in China. Molecular targeted therapies such as gefitinib, an oral inhibitor of …
[PDF] semanticscholar.org

[PDF][PDF] HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer

T Lei, J Huang, F Xie, J Gu… - Acta Biochim …, 2022 - pdfs.semanticscholar.org
Non-small cell lung cancer (NSCLC) ranks the first in incidence and mortality among
malignant tumors in China. Molecular targeted therapies such as gefitinib, an oral inhibitor of …

HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer.

T Lei, J Huang, F Xie, J Gu, Z Cheng… - Acta Biochimica et …, 2022 - europepmc.org
Non-small cell lung cancer (NSCLC) ranks the first in incidence and mortality among
malignant tumors in China. Molecular targeted therapies such as gefitinib, an oral inhibitor of …